International study: BMI alone misclassifies obesity and may lead to inappropriate treatment
Analysis of 844,108 adults in China, UK, US and Spain finds BMI can misclassify obesity; a clinical vs preclinical framework better predicts outcomes.

A large international analysis of health records from 844,108 adults in China, the United Kingdom, the United States and Spain shows that using body mass index (BMI) alone can both overestimate and underestimate obesity, with potential consequences for inappropriate treatment.
Study questions one-size-fits-all BMI threshold
The research, published in the journal Nature, compared standard BMI classification with a framework proposed in January 2025 by a commission in Lancet Diabetes & Endocrinology that separates obesity into two categories: clinical obesity, where excess fat impairs organ function or daily activities, and preclinical obesity, where excess fat increases health risk but normal body function remains intact.
Researchers led by Professor Francesco Rubino, head of the Department of Metabolic and Bariatric Surgery at King’s College London, and first author An Pan of Huazhong University of Science and Technology analysed how alternative measures affected classification and long-term outcomes.
The team found that BMI alone produced incorrect assessments across all four populations. Adding waist circumference and waist-to-height ratio to BMI reduced misclassification: BMI-only approaches missed signs of excess body fat indicating obesity in up to 8.6% of participants, while up to 3.1% were wrongly classified as having obesity.
Clinical obesity, the authors report, made up between 23% and 31% of all obesity cases in their study cohorts, with a population prevalence ranging from 5.6% to 10.9%. The two categories were linked to markedly different outcomes: clinical obesity carried a substantially higher risk of mortality, while preclinical obesity showed only a more modest increase in risk. Between 77% and 91% of people initially classified with preclinical obesity in the study did not progress to clinical obesity over 10 years.
"People with obesity deserve care tailored to their needs — neither less nor more," Professor Rubino said, arguing that BMI by itself cannot tell whether someone is already ill or simply at increased risk.
"The pronounced differences in prognosis between clinical and preclinical obesity, consistently observed across countries and ethnic groups, support the global adoption of the new framework to improve care and obesity policies worldwide," said An Pan.
The authors propose that distinguishing clinical from preclinical obesity would help clinicians decide who needs treatment for existing disease and who would benefit from preventive interventions, instead of applying the same approach to everyone with a high BMI.
Photo: press material from the event


